Yama Lea’s Shield Contraceptive Market Strategy To Focus On Convenience
This article was originally published in The Gray Sheet
Executive Summary
Yama, Inc. is positioning its Lea's Shield reusable barrier contraceptive device as "more convenient" than traditional diaphragms
You may also be interested in...
FemCap Barrier Contraceptive To Launch In May; Licensing Partner Sought
FemCap, Inc. is seeking to license its female barrier contraceptive to potential marketing partners to facilitate broad adoption of the product
FemCap Barrier Contraceptive To Launch In May; Licensing Partner Sought
FemCap, Inc. is seeking to license its female barrier contraceptive to potential marketing partners to facilitate broad adoption of the product
Lea’s Shield Clinical Investigator Warned For Improper Informed Consent
Informed consent and records violations by clinical investigator Mitchell Creinin, MD, University of Pittsburgh, during the pivotal trial for Yama, Inc.'s Lea's Shield were significant enough to draw a warning letter, but did not hinder approval of the PMA